Literature DB >> 19404281

Angiotensin II type 2 receptor in chronic kidney disease: the good side of angiotensin II?

Karen A Griffin1, Anil K Bidani.   

Abstract

Angiotensin II is believed to mediate blood pressure-independent progressive renal damage in chronic kidney disease (CKD). The evidence is less definitive than has been implied, and the studies by Benndorf et al. suggest that angiotensin II acting through its type 2 receptor may even have beneficial effects, although the responsible mechanisms remain to be defined. These and other data suggest that the concept of blood pressure-independent angiotensin signaling being uniformly deleterious in CKD is an oversimplification that needs re-evaluation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19404281     DOI: 10.1038/ki.2009.59

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

1.  Comparison of Effects of ACEIs and ARBs on Albuminuria and Hyperkalemia in Indonesian Hypertensive Type 2 Diabetes Mellitus Patients.

Authors:  Putri S Agustina; Em Yunir; Pukovisa Prawiroharjo; Johanda Damanik; Rani Sauriasari
Journal:  Int J Hypertens       Date:  2020-07-29       Impact factor: 2.420

Review 2.  Hypertension and chronic kidney disease progression: why the suboptimal outcomes?

Authors:  Anil K Bidani; Karen A Griffin; Murray Epstein
Journal:  Am J Med       Date:  2012-08-17       Impact factor: 4.965

Review 3.  Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease.

Authors:  Karen A Griffin
Journal:  Hypertension       Date:  2017-07-31       Impact factor: 10.190

Review 4.  Renal microvascular dysfunction, hypertension and CKD progression.

Authors:  Anil K Bidani; Aaron J Polichnowski; Rodger Loutzenhiser; Karen A Griffin
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-01       Impact factor: 2.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.